(Bloomberg) — GoodRx Inc., a price-comparison platform for prescription drugs, has filed for a potential initial public offering with the U.S. Securities and Exchange Commission, Reuters reported, citing people familiar with the matter.
The Santa Monica, California-based company was valued at $2.8 billion in August 2018 after the private equity firm Silver Lake Management LLC took a major stake. GoodRx is in the process of hiring advisers for the IPO and a listing could come later in 2020 or in early 2021, one person told Reuters.
GoodRx gathers prices and discounts for prescription drugs. It doesn’t sell the drugs, but directs consumers to the drugstore with the best deal and offers coupons. Last year, it bought the startup HeyDoctor LLC in a move to provide virtual medical care.
Co-Chief Executive Doug Hirsch co-founded the company in 2011. He’s a former executive at Facebook Inc.
GoodRx didn’t immediately respond to a Reuters request for comment.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="For more articles like this, please visit us at bloomberg.com” data-reactid=”17″>For more articles like this, please visit us at bloomberg.com
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Subscribe now to stay ahead with the most trusted business news source.” data-reactid=”18″>Subscribe now to stay ahead with the most trusted business news source.
©2020 Bloomberg L.P.
Add Comment